Working Together
What our partners say
We share a common vision with our partners in wanting to make a difference and develop new and advanced medicines that make a real impact on patients’ lives. Hear what they have to say about their partnering journey with us.
-
Our Partners
Learn about our collaboration with Dicerna to develop novel treatments for liver diseases, including NASH
-
Our Partners
Hear how we’re working together with Autifony on a novel therapeutic approach to a range of CNS disorders.
-
Our Partners
Jon Weidanz, CSO, talks about re-imagining cancer immunotherapy and the essential ingredients for successful partnerships.
-
Our Partners
Russell Herndon, CEO & President, talks about partnering with Boehringer Ingelheim on novel areas of science in CNS and CardioMetabolic diseases